Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,085.62
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
1,085.62
Bid (Size)
891.00 (1)
Ask (Size)
1,726.13 (1)
Prev. Close
1,085.62
Today's Range
1,085.62 - 1,085.62
52wk Range
715.54 - 1,106.16
Shares Outstanding
91,779,465
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Stocks to Buy: 7 Founder-Led Companies Set to Outperform
July 17, 2024
These founder-led companies are at the forefront of industry innovation, and historical trends indicate that they will likely outperform.
Via
InvestorPlace
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
July 16, 2024
Via
Benzinga
Performance
YTD
+19.96%
+19.96%
1 Month
+3.85%
+3.85%
3 Month
+20.47%
+20.47%
6 Month
+16.84%
+16.84%
1 Year
+49.42%
+49.42%
More News
Read More
CPI Data Sparks Rally in Biotech Stocks
July 15, 2024
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling
July 15, 2024
Via
Benzinga
The Analyst Landscape: 14 Takes On Regeneron Pharmaceuticals
July 11, 2024
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,300 Today
July 04, 2024
Via
Benzinga
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
July 02, 2024
Via
Benzinga
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
June 25, 2024
Via
Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
July 15, 2024
Via
The Motley Fool
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
July 09, 2024
Via
InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
July 08, 2024
Via
Talk Markets
3 No-Brainer Stocks to Buy in July
July 08, 2024
Via
The Motley Fool
3 Pharma Stocks Already Ushering in the Next Biotech Boom
July 08, 2024
Via
InvestorPlace
The 3 Best Biotech Stocks to Buy in July 2024
July 05, 2024
Via
InvestorPlace
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
Via
Investor's Business Daily
7 High Priced Stocks That Would Benefit From a Stock Split
July 04, 2024
Via
InvestorPlace
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
July 03, 2024
Via
Benzinga
Exposures
Product Safety
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
July 03, 2024
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
What's Going On With Regeneron Pharmaceuticals Stock On Friday?
June 28, 2024
Via
Benzinga
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
June 28, 2024
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
June 27, 2024
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
June 27, 2024
Via
Benzinga
Exposures
Product Safety
3 Biotech Stocks That Could Make Your Grandchildren Rich
June 27, 2024
Via
InvestorPlace
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
June 26, 2024
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron Pharmaceuticals' Approach To Improve Quality Of Weight Loss Has Merit: Goldman Sachs
June 24, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.